MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GROPPI, V. E.
Right arrow Articles by BROWNING, E. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GROPPI, V. E., JR.
Right arrow Articles by BROWNING, E. T.

Molecular Pharmacology, Vol 18, 427-437, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Norepinephrine-Dependent Protein Phosphorylation in Intact C-6 Glioma Cells

Analysis by Two-Dimensional Gel Electrophoresis

VINCENT E. GROPPI JR. 1 and EDWARD T. BROWNING 1

1 Department of Pharmacology, College of Medicine and Dentistry of New Jersey, Rutgers Medical School, Piscataway, New Jersey 08854

Norepinephrine rapidly induced phosphorylation of 7 of the more than 200 neutral and acidic phosphoproteins which were resolved by two-dimensional gel electrophoresis of a whole cell extract of C-6 glioma cells. Cellular ATP pools were nearly optimally labeled by 32Pi, after a 4-hr exposure, and norepinephrine treatment did not modify the specific radioactivity of the ggr-phosphate of cellular ATP. That the 32P-labeled spots of two-dimensional gels were indeed phosphopolypeptides was verified by comparing the migration of 35S-methionine-labe1ed and 32Pi-labeled samples and by extensive solvent extractions and chemical treatments. Subcellular fractionation resulted in assignment of a subcellular compartment to five of the seven norepinephrine-dependent phosphopolypeptides. These modified proteins were designated the "phosphoprotein domain" of norepinephrine for the C-6 glioma cell and each was provisionally named in terms of molecular weight, isoelectric point, and, where possible, subcellular compartment. Accordingly the proteins were named: 58K-5.7-nuclear; 50K-6.1, 48K-6.8-cytosolic; 38K-6.4-cytosolic; 20K-6.2, 19K-6.6-mitochondrial; and 16.5K-6.3-cytosolic. We have concluded that protein 58K-5.7-nuclear is the intermediate filament protein of the C-6 glioma cell based on similarities of molecular weight, isoelectric point, abundance, subcellular fractionation, nuclear binding, and elution as well as phosphorylation.

Submitted on December 10, 1979
Accepted on July 8, 1980







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics